Stay updated on Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel

Sign up to get notified when there's something new on the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page

  1. Check
    2 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.4%
    Check dated 2025-06-21T19:32:22.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-14T13:46:49.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-07T07:31:55.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.7%
    Check dated 2025-05-31T00:53:26.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-23T23:16:24.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has removed a citation regarding an erratum for a study on the pharmacokinetics of a trastuzumab biosimilar, while the original citation remains.
    Difference
    0.2%
    Check dated 2025-05-16T19:54:43.000Z thumbnail image

Stay in the know with updates to Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel

Enter your email address, and we'll notify you when there's something new on the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page.